Literature DB >> 2953407

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.

C A Altar, K Hauser.   

Abstract

Iodinated SCH 23390, [125I]SCH 23982, saturably binds in brain to D1 receptors that mostly reside on striatal and striatonigral neurons. [125I]SCH 23982 autoradiography was used to determine the topography of D1 receptor-containing striatal inputs to subregions of the substantia nigra. The concentration of D1 sites was greatest in the pars reticulata of the substantia nigra and exceeded by over 50% the equal concentrations of D1 sites in the lateral substantia nigra, caudate-putamen, nucleus accumbens, and olfactory tubercle. D1 receptors were uniformly concentrated throughout the caudate-putamen and were absent in the pars compacta of the substantia nigra and ventral tegmental area. Injections into the rostral striatum of the axon-sparing neurotoxin, quinolinic acid, depleted the concentration of D1 sites in the rostral caudate-putamen by 98% and the concentration of D1 sites in the medial substantia nigra by up to 74%. Quinolinic acid-induced losses of the D1 sites in the central striatum of up to 85% were associated with 87% losses of D1 sites in the central nigra. D1 losses of 91% in the caudal striatum were associated with D1 losses of 85% in the lateral nigra. Thus, most D1 sites in the striatum reside on neurons that are intrinsic to that brain region, and the vast majority of D1 sites in the substantia nigra are on the terminals of striatonigral neurons. These D1 receptor-containing striatonigral neurons have a rostral, central, or caudal origin in the striatum and a corresponding medial, central, or lateral termination in the nigra. This topographical organization of striatal inputs to the substantia nigra indicates that substance P or dynorphin B-containing striatonigral neurons may have D1 receptors on their terminals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953407     DOI: 10.1016/s0006-8993(87)80014-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Dopamine D1 heteroreceptors on striatonigral axons are not stimulated by endogeneous dopamine either tonically or after amphetamine: evidence from terminal excitability.

Authors:  L J Ryan; M Diana; S J Young; P M Groves
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.

Authors:  A Emmi; H Rajabi; J Stewart
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

4.  Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.

Authors:  T Momiyama; M Sasa; S Takaori
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.

Authors:  F Karoum; M F Egan
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Authors:  M S Cousins; W Wei; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.

Authors:  T Momiyama; N Todo; M Sasa
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.

Authors:  Anders Borgkvist; Elizabeth M Avegno; Minerva Y Wong; Mazen A Kheirbek; Mark S Sonders; Rene Hen; David Sulzer
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

9.  Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus.

Authors:  Q Huang; D Zhou; K Chase; J F Gusella; N Aronin; M DiFiglia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Substance P analogs displace sigma binding differentially in the brain and spinal cord of the adult mouse.

Authors:  D D Mousseau; A A Larson
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.